RRX Regal Rexnord | $215.06 +3.4% | 7/10/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 7/10/2026 |
RRX Regal Rexnord | $215.06 +3.4% | 7/10/2026 | | Set Price Target | $255.00 | | 00.00% | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 7/10/2026 |
EWTX Edgewise Therapeutics | $45.41 -6.1% | 7/9/2026 | | Initiated Coverage | $51.00 | Outperform | 00.00% | View details for Oppenheimer rating of Edgewise Therapeutics (NASDAQ:EWTX) on 7/9/2026 |
CNTB Connect Biopharma | $2.51 -5.6% | 7/9/2026 | | Initiated Coverage | $8.00 | Outperform | 00.00% | View details for Oppenheimer rating of Connect Biopharma (NASDAQ:CNTB) on 7/9/2026 |
SAR Saratoga Investment | $18.15 +4.0% | 7/9/2026 | | Lower Price Target | $22.00 ➝ $21.00 | Market Perform | 00.00% | View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 7/9/2026 |
WM Waste Management | $233.50 +0.8% | 7/8/2026 | | Lower Price Target | $264.00 ➝ $263.00 | Outperform | 00.00% | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 7/8/2026 |
CMPS Compass Pathways | $13.64 +0.3% | 7/7/2026 | | Reiterated Rating | $20.00 | Outperform | 00.00% | View details for Oppenheimer rating of Compass Pathways (NASDAQ:CMPS) on 7/7/2026 |
GLW Corning | $191.12 -0.7% | 7/7/2026 | | Boost Price Target | $210.00 ➝ $230.00 | Outperform | 00.00% | View details for Oppenheimer rating of Corning (NYSE:GLW) on 7/7/2026 |
CRNX Crinetics Pharmaceuticals | $83.58 0.0% | 7/7/2026 | | Reiterated Rating | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/7/2026 |
ORN Orion Group | $13.74 -2.1% | 7/7/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Oppenheimer rating of Orion Group (NYSE:ORN) on 7/7/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
PRIM Primoris Services | $86.73 -3.0% | 7/7/2026 | | Initiated Coverage | $135.00 | Outperform | 00.00% | View details for Oppenheimer rating of Primoris Services (NYSE:PRIM) on 7/7/2026 |
TRMB Trimble | $52.82 +0.2% | 7/7/2026 | | Reiterated Rating | $80.00 | Outperform | 00.00% | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 7/7/2026 |
KYNB Kyntra Bio | $7.61 +4.0% | 7/6/2026 | | Initiated Coverage | $35.00 | Outperform | 00.00% | View details for Oppenheimer rating of Kyntra Bio (NASDAQ:KYNB) on 7/6/2026 |
PRGS Progress Software | $37.86 -1.7% | 7/1/2026 | | Lower Price Target | $57.00 ➝ $50.00 | Outperform | 00.00% | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 7/1/2026 |
XYZ Block | $77.32 -0.1% | 6/30/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Block (NYSE:XYZ) on 6/30/2026 |
USB U.S. Bancorp | $62.49 +1.0% | 6/30/2026 | | Lower Price Target | $74.00 ➝ $73.00 | Outperform | 00.00% | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 6/30/2026 |
BROS Dutch Bros | $67.71 +3.2% | 6/30/2026 | | Boost Price Target | $72.00 ➝ $82.00 | Outperform | 00.00% | View details for Oppenheimer rating of Dutch Bros (NYSE:BROS) on 6/30/2026 |
PALI Palisade Bio | $1.96 -0.5% | 6/30/2026 | | Set Price Target | $7.00 | | 00.00% | View details for Oppenheimer rating of Palisade Bio (NASDAQ:PALI) on 6/30/2026 |
C Citigroup | $140.67 +0.8% | 6/30/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Citigroup (NYSE:C) on 6/30/2026 |
BAC Bank of America | $59.68 +0.7% | 6/30/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 6/30/2026 |
GS The Goldman Sachs Group | $1,056.04 +0.0% | 6/30/2026 | | Downgrade | | Market Perform ➝ Underperform | 00.00% | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 6/30/2026 |
MS Morgan Stanley | $222.21 +0.0% | 6/30/2026 | | Downgrade | | Market Perform ➝ Underperform | 00.00% | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 6/30/2026 |
PNC The PNC Financial Services Group | $251.99 +0.4% | 6/30/2026 | | Boost Price Target | $268.00 ➝ $271.00 | Outperform | 00.00% | View details for Oppenheimer rating of The PNC Financial Services Group (NYSE:PNC) on 6/30/2026 |
SEZL Sezzle | $179.38 +1.3% | 6/29/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Sezzle (NASDAQ:SEZL) on 6/29/2026 |
ARMK Aramark | $57.94 +0.1% | 6/29/2026 | | Boost Price Target | $60.00 ➝ $65.00 | Outperform | 00.00% | View details for Oppenheimer rating of Aramark (NYSE:ARMK) on 6/29/2026 |
NRIX Nurix Therapeutics | $23.06 -6.6% | 6/29/2026 | | Initiated Coverage | $28.00 | Outperform | 00.00% | View details for Oppenheimer rating of Nurix Therapeutics (NASDAQ:NRIX) on 6/29/2026 |
VSAT Viasat | $73.56 +4.5% | 6/29/2026 | | Initiated Coverage | $140.00 | Outperform | 00.00% | View details for Oppenheimer rating of Viasat (NASDAQ:VSAT) on 6/29/2026 |
AYI Acuity | $332.78 -0.6% | 6/26/2026 | | Set Price Target | $465.00 | | 00.00% | View details for Oppenheimer rating of Acuity (NYSE:AYI) on 6/26/2026 |
ACA Arcosa | $145.03 +0.0% | 6/26/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 6/26/2026 |
NKE NIKE | $44.39 +3.8% | 6/26/2026 | | Lower Price Target | $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of NIKE (NYSE:NKE) on 6/26/2026 |
EPRX Eupraxia Pharmaceuticals | $6.68 -3.3% | 6/25/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Oppenheimer rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 6/25/2026 |
GHC Graham | $1,160.16 +0.2% | 6/25/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Graham (NYSE:GHC) on 6/25/2026 |
JEF Jefferies Financial Group | $52.04 -0.8% | 6/25/2026 | | Lower Price Target | $87.00 ➝ $83.00 | Outperform | 00.00% | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 6/25/2026 |
GHM Graham | $107.96 -0.6% | 6/25/2026 | | Boost Price Target | $130.00 | Outperform | 00.00% | View details for Oppenheimer rating of Graham (NYSE:GHM) on 6/25/2026 |
LTH Life Time Group | $41.85 +0.4% | 6/25/2026 | | Boost Price Target | $43.00 ➝ $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Life Time Group (NYSE:LTH) on 6/25/2026 |
FIG Figma | $21.10 -5.2% | 6/25/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Figma (NYSE:FIG) on 6/25/2026 |
DFTX Definium Therapeutics | $47.07 -2.8% | 6/22/2026 | | Set Price Target | $40.00 ➝ $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Definium Therapeutics (NASDAQ:DFTX) on 6/22/2026 |
BBOT BridgeBio Oncology Therapeutics | $8.32 -8.5% | 6/22/2026 | | Initiated Coverage | $22.00 | Outperform | 00.00% | View details for Oppenheimer rating of BridgeBio Oncology Therapeutics (NASDAQ:BBOT) on 6/22/2026 |
ONTO Onto Innovation | $321.53 +1.4% | 6/22/2026 | | Boost Price Target | $370.00 ➝ $450.00 | Outperform | 00.00% | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 6/22/2026 |
RLJ RLJ Lodging Trust | $11.47 +1.1% | 6/18/2026 | | Reiterated Rating | $10.00 ➝ $13.00 | Outperform | 00.00% | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 6/18/2026 |
Free: The Crypto Summit That Could Change Your Life (Ad) Markets move quickly. But the ideas that can help you make better investing decisions often come from listening to the people building the industry—not just reacting to price charts.
That's exactly what you'll get at the Crypto Community Summit.
Over three days, 27 leading crypto experts will share what they're paying attention to, where they see opportunity developing, and how they're approaching today's market environment. Claim Your FREE Pass ($799 Value) |
SPCX SpaceX | $145.30 -4.5% | 6/18/2026 | | Boost Price Target | $190.00 ➝ $250.00 | Outperform | 00.00% | View details for Oppenheimer rating of SpaceX (NASDAQ:SPCX) on 6/18/2026 |
SMWB Similarweb | $6.70 +1.7% | 6/18/2026 | | Boost Price Target | $4.00 ➝ $7.00 | Outperform | 00.00% | View details for Oppenheimer rating of Similarweb (NYSE:SMWB) on 6/18/2026 |
DRI Darden Restaurants | $204.21 +1.1% | 6/18/2026 | | Reiterated Rating | $235.00 | Outperform | 00.00% | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 6/18/2026 |
HLNE Hamilton Lane | $81.09 +0.6% | 6/18/2026 | | Lower Price Target | $179.00 ➝ $176.00 | Outperform | 00.00% | View details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 6/18/2026 |
ODTX Odyssey Therapeutics | $16.69 -0.8% | 6/18/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Oppenheimer rating of Odyssey Therapeutics (NASDAQ:ODTX) on 6/18/2026 |
LYFT Lyft | $15.61 -0.8% | 6/17/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Oppenheimer rating of Lyft (NASDAQ:LYFT) on 6/17/2026 |
MIDD Middleby | $135.67 +1.8% | 6/17/2026 | | Initiated Coverage | $205.00 | Outperform | 00.00% | View details for Oppenheimer rating of Middleby (NASDAQ:MIDD) on 6/17/2026 |
CRBP Corbus Pharmaceuticals | $9.68 +0.2% | 6/17/2026 | | Lower Price Target | $54.00 ➝ $52.00 | Outperform | 00.00% | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 6/17/2026 |
BV BrightView | $14.30 +0.1% | 6/17/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Oppenheimer rating of BrightView (NYSE:BV) on 6/17/2026 |
ROKU Roku | $140.69 +0.3% | 6/15/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Roku (NASDAQ:ROKU) on 6/15/2026 |
CDNL Cardinal Infrastructure Group | $68.14 -3.5% | 6/15/2026 | | Boost Price Target | $60.00 ➝ $80.00 | Outperform | 00.00% | View details for Oppenheimer rating of Cardinal Infrastructure Group (NASDAQ:CDNL) on 6/15/2026 |
LRCX Lam Research | $350.33 -0.8% | 6/15/2026 | | Reiterated Rating | $330.00 ➝ $400.00 | Outperform | 00.00% | View details for Oppenheimer rating of Lam Research (NASDAQ:LRCX) on 6/15/2026 |
INSP Inspire Medical Systems | $52.03 +1.0% | 6/15/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Inspire Medical Systems (NYSE:INSP) on 6/15/2026 |
ADBE Adobe | $223.64 +0.4% | 6/12/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 6/12/2026 |
JEF Jefferies Financial Group | $52.04 -0.8% | 6/12/2026 | | Boost Price Target | $72.00 ➝ $87.00 | Outperform | 00.00% | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 6/12/2026 |
INTC Intel | $109.84 -2.4% | 6/11/2026 | | Initiated Coverage | | Market Perform ➝ Outperform | 00.00% | View details for Oppenheimer rating of Intel (NASDAQ:INTC) on 6/11/2026 |
NAVN Navan | $25.92 +1.1% | 6/11/2026 | | Set Price Target | $30.00 | | 00.00% | View details for Oppenheimer rating of Navan (NASDAQ:NAVN) on 6/11/2026 |
SPCX SpaceX | $145.30 -4.5% | 6/11/2026 | | Set Price Target | $190.00 | Outperform | 00.00% | View details for Oppenheimer rating of SpaceX (NASDAQ:SPCX) on 6/11/2026 |
WDAY Workday | $138.95 +0.4% | 6/11/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 6/11/2026 |
BKH Black Hills | $75.14 +2.5% | 6/11/2026 | | Set Price Target | $78.00 | | 00.00% | View details for Oppenheimer rating of Black Hills (NYSE:BKH) on 6/11/2026 |
TSLA Tesla | $407.76 +0.3% | 6/11/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 6/11/2026 |
ARMK Aramark | $57.94 +0.1% | 6/11/2026 | | Boost Price Target | $50.00 ➝ $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Aramark (NYSE:ARMK) on 6/11/2026 |
MYRG MYR Group | $419.34 -2.7% | 6/11/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of MYR Group (NASDAQ:MYRG) on 6/11/2026 |
SPCX SpaceX | $145.30 -4.5% | 6/11/2026 | | Initiated Coverage | $190.00 ➝ $250.00 | Outperform | 00.00% | View details for Oppenheimer rating of SpaceX (NASDAQ:SPCX) on 6/11/2026 |
AOS A. O. Smith | $60.52 +2.5% | 6/10/2026 | | Set Price Target | $80.00 ➝ $75.00 | Outperform | 00.00% | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 6/10/2026 |
IKT Inhibikase Therapeutics | $2.04
| 6/10/2026 | | Initiated Coverage | $5.00 | Outperform | 00.00% | View details for Oppenheimer rating of Inhibikase Therapeutics (NASDAQ:IKT) on 6/10/2026 |
TOL Toll Brothers | $149.37 +0.7% | 6/9/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 6/9/2026 |
GHM Graham | $107.96 -0.6% | 6/9/2026 | | Boost Price Target | $100.00 ➝ $110.00 | Outperform | 00.00% | View details for Oppenheimer rating of Graham (NYSE:GHM) on 6/9/2026 |
UCTT Ultra Clean | $106.27 +0.1% | 6/9/2026 | | Boost Price Target | $100.00 ➝ $115.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ultra Clean (NASDAQ:UCTT) on 6/9/2026 |
ASND Ascendis Pharma A/S | $270.45 -1.8% | 6/9/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 6/9/2026 |
AAPL Apple | $315.32 -0.3% | 6/9/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 6/9/2026 |
DTIL Precision BioSciences | $8.76 -4.4% | 6/9/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Oppenheimer rating of Precision BioSciences (NASDAQ:DTIL) on 6/9/2026 |
LYTS LSI Industries | $24.16 -1.0% | 6/9/2026 | | Initiated Coverage | $30.00 | Outperform | 00.00% | View details for Oppenheimer rating of LSI Industries (NASDAQ:LYTS) on 6/9/2026 |
INGR Ingredion | $98.68 +1.2% | 6/8/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 6/8/2026 |
INCY Incyte | $116.71 -1.5% | 6/8/2026 | | Reiterated Rating | $107.00 | Market Perform | 00.00% | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 6/8/2026 |
ACN Accenture | $135.19 -2.8% | 6/8/2026 | | Set Price Target | $201.00 | | 00.00% | View details for Oppenheimer rating of Accenture (NYSE:ACN) on 6/8/2026 |
ORCL Oracle | $140.69 -2.4% | 6/8/2026 | | Boost Price Target | $235.00 ➝ $275.00 | Outperform | 00.00% | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 6/8/2026 |
TKR Timken | $137.16 -0.6% | 6/5/2026 | | Boost Price Target | $137.00 ➝ $147.00 | Outperform | 00.00% | View details for Oppenheimer rating of Timken (NYSE:TKR) on 6/5/2026 |
LQDA Liquidia | $77.93 -4.3% | 6/5/2026 | | Set Price Target | $75.00 | | 00.00% | View details for Oppenheimer rating of Liquidia (NASDAQ:LQDA) on 6/5/2026 |
NAVN Navan | $25.92 +1.1% | 6/5/2026 | | Boost Price Target | $20.00 ➝ $28.00 | Outperform | 00.00% | View details for Oppenheimer rating of Navan (NASDAQ:NAVN) on 6/5/2026 |
RBRK Rubrik | $84.23 -5.1% | 6/5/2026 | | Boost Price Target | $85.00 ➝ $90.00 | Outperform | 00.00% | View details for Oppenheimer rating of Rubrik (NYSE:RBRK) on 6/5/2026 |
NTSK Netskope | $12.32 -0.8% | 6/4/2026 | | Lower Price Target | $19.00 ➝ $16.00 | Outperform | 00.00% | View details for Oppenheimer rating of Netskope (NASDAQ:NTSK) on 6/4/2026 |
AVGO Broadcom | $399.97 -0.3% | 6/4/2026 | | Reiterated Rating | $450.00 ➝ $535.00 | Outperform | 00.00% | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 6/4/2026 |
VEEV Veeva Systems | $190.27 +0.3% | 6/4/2026 | | Reiterated Rating | $225.00 | Outperform | 00.00% | View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 6/4/2026 |
NN NextNav | $16.00 -5.4% | 6/3/2026 | | Boost Price Target | $25.00 ➝ $50.00 | Outperform | 00.00% | View details for Oppenheimer rating of NextNav (NASDAQ:NN) on 6/3/2026 |
T AT&T | $21.16 +0.5% | 6/3/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Oppenheimer rating of AT&T (NYSE:T) on 6/3/2026 |
ALM Almonty Industries | $16.61 +13.0% | 6/3/2026 | | Boost Price Target | $22.00 ➝ $25.00 | Outperform | 00.00% | View details for Oppenheimer rating of Almonty Industries (NASDAQ:ALM) on 6/3/2026 |
IRDM Iridium Communications | $50.06 -1.1% | 6/3/2026 | | Boost Price Target | $48.00 ➝ $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Iridium Communications (NASDAQ:IRDM) on 6/3/2026 |
PANW Palo Alto Networks | $325.91 -3.7% | 6/3/2026 | | Boost Price Target | $275.00 ➝ $350.00 | Outperform | 00.00% | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 6/3/2026 |
SHAK Shake Shack | $58.58 +4.0% | 6/2/2026 | | Set Price Target | $82.00 | Outperform | 00.00% | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 6/2/2026 |
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
URGN Urogen Pharma | $38.56 -4.2% | 6/2/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Urogen Pharma (NASDAQ:URGN) on 6/2/2026 |
PRAX Praxis Precision Medicines | $324.99 -2.4% | 6/2/2026 | | Reiterated Rating | $750.00 ➝ $650.00 | Outperform | 00.00% | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2026 |
IEX IDEX | $222.33 +1.2% | 6/2/2026 | | Reiterated Rating | $242.00 ➝ $250.00 | Outperform | 00.00% | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 6/2/2026 |
JCI Johnson Controls International | $142.95 +1.7% | 6/2/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 6/2/2026 |
ODTX Odyssey Therapeutics | $16.69 -0.8% | 6/2/2026 | | Initiated Coverage | $40.00 | Outperform | 00.00% | View details for Oppenheimer rating of Odyssey Therapeutics (NASDAQ:ODTX) on 6/2/2026 |
IMRX Immuneering | $5.11 -4.7% | 6/1/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 6/1/2026 |
RVMD Revolution Medicines | $186.88 -2.2% | 6/1/2026 | | Boost Price Target | $165.00 ➝ $195.00 | Outperform | 00.00% | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 6/1/2026 |
ONTO Onto Innovation | $321.53 +1.4% | 6/1/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 6/1/2026 |
VIA Via Transportation | $17.98 -1.8% | 6/1/2026 | | Reiterated Rating | $25.00 | Outperform | 00.00% | View details for Oppenheimer rating of Via Transportation (NYSE:VIA) on 6/1/2026 |
DG Dollar General | $118.91 +2.7% | 5/29/2026 | | Lower Price Target | $170.00 ➝ $150.00 | Outperform | 00.00% | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 5/29/2026 |